Purchase Order 75F40119P10055
- Not listed
- This federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Sartorius Stedim North America Inc., a subsidiary of the German company Sartorius Aktiengesellschaft. The $89,489.60 Firm Fixed Price Purchase Order is for the supply of bioreactor parts and accessories. The contract does not have a set-aside designation. Sartorius Stedim North America Inc. is a leading provider of laboratory...
- The Department of Health and Human Services Food and Drug Administration has awarded a firm-fixed-price purchase order valued at $211,279.00 to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft. The contract is for the delivery of the AMBR250 4-WAY MODULAR SYSTEM, which is a bioreactor product used to support the biopharmaceutical manufacturing process. Sartorius Stedim North America Inc. is a leading provider of laboratory equipment, consumables,...
- This is a $210,267.91 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Sartorius Stedim North America Inc., a subsidiary of the German company Sartorius Aktiengesellschaft. The contract is for the delivery of off-line gas analyzers, on-line and integral nutrient analyzers, bioreactor probes, and accessories for a Sartorius BIOSTAT bioreactor system. This award does not have a set-aside designation. Sartorius Stedim North America...
- The Food and Drug Administration awarded a $86.8K firm fixed-price purchase order to Sartorius Stedim North America Inc. for operational parts and software updates to Biostat B-DCU II bioprocess control units equipped with BioPat analytics systems. The contract, awarded on September 17, 2019, with a completion date of January 30, 2020, represents a non-set-aside procurement for specialized biopharmaceutical manufacturing support equipment. Sartorius Stedim North America Inc., a subsidiary of...
- Sartorius Stedim North America, Inc. was awarded a $126,870 purchase order by the Department of Health and Human Services' Food and Drug Administration to provide bioreactor parts and components. As the prime contractor, Sartorius Stedim North America will deliver the requested biomanufacturing equipment components from its Bohemia, New York facility in support of the FDA's regulatory and research programs. The firm fixed price contract runs from August 2023 through September 2024. No set...
- Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft, has been awarded a $46,330.00 firm fixed price purchase order contract by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center. The contract, which does not have a set-aside designation, is for the delivery of various laboratory equipment and consumables, including bioreactors, filtration systems, and analytical testing products, to support the...
- This is a $17,904.60 firm fixed-price purchase order awarded by a civilian federal agency to Sartorius Stedim North America Inc., a subsidiary of the German company Sartorius Aktiengesellschaft. The award is for a BIOSTAT A UNIVESSEL (BIOREACTOR 1L) reference quotation #1411-MHH-5980. This contract was not set aside and does not appear to be associated with a larger contract vehicle. Sartorius Stedim North America Inc. is a leading provider of advanced laboratory equipment, consumables, and...
- Sartorius Stedim North America Inc. was awarded a $326,622.90 firm fixed-price purchase order by the U.S. Department of Agriculture's Agricultural Research Services to supply and install a Biostat B bioreactor dual control unit at the National Center for Agricultural Utilization Research (NCAUR) in Bohemia, New York. The contract, awarded on September 6, 2024, with completion by January 4, 2025, fulfills the government's requirement for a dual control unit compatible with existing B. Braun...
- This is a $6,806 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft. The contract is for the delivery of 01-GMP TPO, 50UG, a biopharmaceutical product or laboratory equipment, with a period of performance through April 17, 2025. Sartorius Stedim North America is a leading provider of laboratory equipment, consumables, and services supporting...
- This $215,273 firm-fixed-price purchase order contract was awarded by the Plains Area, a civilian agency, to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions for the biopharmaceutical and life sciences industries. The contract is for the installation and training of large-scale bioreactors, which are essential for efficiently producing biologics in quantities suitable for commercial scale-up operations while maintaining quality. The contract...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft. The $198,816.00 fixed-price contract is for maintenance on a Sartorius Biostat B-DCU II parallel bioreactor system. The contract has no set-aside designation and was awarded on December 20, 2018, with a completion date of January 1, 2022. Sartorius Stedim North America Inc. has fulfilled over $2 million in federal contracts since 2019 to provide bioreactors, filtration systems, software platforms, and testing supplies to the Department of Health and Human Services, the Food and Drug Administration, the Environmental Protection Agency, and other agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $67.6k | 12/1/20 | |
| P00001 | Exercise an Option | $65.6k | 11/15/19 | |
| Not listed | Not listed | $65.6k | 12/20/18 |